Relationship Between Buprenorphine Adherence and Health Service Utilization and Costs Among Opioid Dependent Patients.
作者： Joseph Tkacz , Joseph Volpicelli , Hyong Un , Charles Ruetsch
DOI: 10.1016/J.JSAT.2013.10.014
关键词:
摘要: Abstract Buprenorphine-medication assisted therapy (B-MAT) is an effective treatment for opioid dependence, but may be considered cost-prohibitive based on ingredient cost alone. The purpose of this study was to use medical and pharmacy claims data estimate the healthcare service utilization costs associated with B-MAT adherence among a sample dependent members. Members were placed into two groups 1-year medication possession ratio (≥0.80 vs. p
sci-hub.se 参考文章(36)
Christopher M Doran, Economic evaluation of interventions to treat opiate dependence : a review of the evidence. PharmacoEconomics. ,vol. 26, pp. 371- 393 ,(2008) , 10.2165/00019053-200826050-00003
ALAN G. WHITE, HOWARD G. BIRNBAUM, MILENA N. MAREVA, MAHAM DAHER, SUSAN VALLOW, JEFF SCHEIN, NATHANIEL KATZ, Direct costs of opioid abuse in an insured population in the United States. Journal of managed care & specialty pharmacy. ,vol. 26, pp. 1188- 1198 ,(2020) , 10.18553/JMCP.2020.26.10.1188
Angelie Singh, Laxmaiah Manchikanti, Therapeutic opioids: a ten-year perspective on the complexities and complications of the escalating use, abuse, and nonmedical use of opioids. Pain Physician. ,vol. 11, ,(2008) , 10.36076/PPJ.2008/11/S63
Benedikt Fischer, Jude Gittins, Jürgen Rehm, Characterizing the “Awakening Elephant” of Prescription Opioid Misuse in North America: Epidemiology, Harms, Interventions Contemporary drug problems. ,vol. 35, pp. 397- 426 ,(2008) , 10.1177/009145090803500210
Howard G. Birnbaum, Alan G. White, Matt Schiller, Tracy Waldman, Jody M. Cleveland, Carl L. Roland, Societal Costs of Prescription Opioid Abuse, Dependence, and Misuse in the United States Pain Medicine. ,vol. 12, pp. 657- 667 ,(2011) , 10.1111/J.1526-4637.2011.01075.X
Joseph Tkacz, Jamie Severt, John Cacciola, Charles Ruetsch, Compliance with buprenorphine medication-assisted treatment and relapse to opioid use. American Journal on Addictions. ,vol. 21, pp. 55- 62 ,(2012) , 10.1111/J.1521-0391.2011.00186.X
Daniel Polsky, Henry A. Glick, Jianing Yang, Geetha A. Subramaniam, Sabrina A. Poole, George E. Woody, Cost-effectiveness of Extended Buprenorphine-Naloxone Treatment for Opioid-Dependent Youth: Data from a Randomized Trial Addiction. ,vol. 105, pp. 1616- 1624 ,(2010) , 10.1111/J.1360-0443.2010.03001.X
Walter Ling, Paul Casadonte, George Bigelow, Kyle M. Kampman, Ashwin Patkar, Genie L. Bailey, Richard N. Rosenthal, Katherine L. Beebe, Buprenorphine Implants for Treatment of Opioid Dependence JAMA. ,vol. 304, pp. 1576- 1583 ,(2010) , 10.1001/JAMA.2010.1427
Jason Cooper, Lakevia Hall, Angel Penland, Andrew Krueger, Jeanette May, Measuring medication adherence. Population Health Management. ,vol. 12, pp. 25- 30 ,(2009) , 10.1089/POP.2008.0031
Laura J. Laakso, Motivational Interviewing: Addressing Ambivalence to Improve Medication Adherence in Patients with Bipolar Disorder Issues in Mental Health Nursing. ,vol. 33, pp. 8- 14 ,(2011) , 10.3109/01612840.2011.618238